Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 29, 2024
April 29, 2024
a430f093-c9f8-4001-aef8-771d98ffdbf0
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Data Integrity for In Vivo Bioavailability and Bioequivalence Studies
Guidance DocumentApril 3, 2024Center for Drug Evaluation and Research
Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products
Guidance DocumentSeptember 8, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox